HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Interleukin-35 mediates mucosal immune responses that protect against T-cell-dependent colitis.

AbstractBACKGROUND & AIMS:
The soluble hematopoietin receptor Epstein-Barr virus-induced protein (EBI)-3 is an immune regulator that has been associated with the pathogenesis of inflammatory bowel disease. However, the concept that EBI3 is part of an interleukin (IL)-27 heterodimer that mediates chronic inflammatory and autoimmune diseases has been challenged by the description of IL-35, a bioactive cytokine comprising EBI3 and IL-12 p35. We investigated the roles of IL-27 and IL-35 in chronic inflammation of the intestine.
METHODS:
We analyzed EBI3-deficient mice and IL-27p28-deficient mice with spontaneous or T-cell transfer-induced colitis and compared outcomes with wild-type mice (controls). We constructed vectors that express EBI3 covalently linked to the IL-12p35 chain (recombinant [r]IL-35).
RESULTS:
Intestines of EBI3-deficient mice had increased pathologic features of colitis, compared with IL-27p28-deficient or control mice; they also had shorter survival times, indicating that IL-35, rather than IL-27, protects the intestine from immune responses in mice. The mucosa of EBI3-deficient mice accumulated subsets of activated CD4+ T cells that produced T-helper (Th)1 and Th17 cytokines. Adoptive transfer of these T cells induced colitis in RAG-deficient mice. The rIL-35 significantly reduced the development of several forms of experimental colitis and reduced levels of markers of Th1 and Th17 cells.
CONCLUSIONS:
IL-35 controls the development of T-cell-dependent colitis in mice. It might be developed as a therapeutic target for patients with chronic intestinal inflammation.
AuthorsStefan Wirtz, Ulrike Billmeier, Tamuna Mchedlidze, Richard S Blumberg, Markus F Neurath
JournalGastroenterology (Gastroenterology) Vol. 141 Issue 5 Pg. 1875-86 (Nov 2011) ISSN: 1528-0012 [Electronic] United States
PMID21820391 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2011 AGA Institute. Published by Elsevier Inc. All rights reserved.
Chemical References
  • Ebi3 protein, mouse
  • Interleukin-12 Subunit p35
  • Interleukins
  • Minor Histocompatibility Antigens
  • Receptors, Cytokine
  • interleukin-35, mouse
Topics
  • Animals
  • Colitis (immunology, metabolism, pathology)
  • Disease Models, Animal
  • Female
  • Immunity, Mucosal (drug effects, physiology)
  • Interleukin-12 Subunit p35 (deficiency, genetics)
  • Interleukins (metabolism, pharmacology)
  • Intestinal Mucosa (metabolism)
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Minor Histocompatibility Antigens
  • Phenotype
  • Receptors, Cytokine (deficiency, genetics)
  • T-Lymphocytes (pathology, physiology)
  • Th1 Cells (pathology, physiology)
  • Th17 Cells (pathology, physiology)
  • Up-Regulation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: